Annual report pursuant to Section 13 and 15(d)

Subsequent Events - Additional Information (Details)

v3.20.1
Subsequent Events - Additional Information (Details) - Subsequent Event
Jan. 21, 2020
USD ($)
Debtinstrument
shares
Iterum Therapeutics Bermuda Limited  
Subsequent Event [Line Items]  
Ownership percentage 100.00%
Subsidiary Guarantors  
Subsequent Event [Line Items]  
Ownership percentage 100.00%
Private Placement | Exchangeable Notes  
Subsequent Event [Line Items]  
Aggregate principal amount $ 51,600,000
Debt instrument price per unit 1,000
Private Placement | RLNs  
Subsequent Event [Line Items]  
Aggregate principal amount $ 100,000
Number of debt instruments within each notes | Debtinstrument 50
Debt instrument, aggregate potential payment capped value $ 160,000
Debt instrument, aggregate potential payment capped rate 4,000 times
Private Placement | Securities  
Subsequent Event [Line Items]  
Debt instrument price per unit $ 1,000
Debt instrument, shares embedded within each unit, shares | shares 1,000
Debt instrument, shares embedded within each unit, value $ 1,000
Proceeds from sale of securities $ 46,700,000
Minimum | Private Placement | RLNs  
Subsequent Event [Line Items]  
Debt instrument, percentage of net revenue from domestic sale for potential aggregate payments 15.00%
Maximum | Private Placement | RLNs  
Subsequent Event [Line Items]  
Debt instrument, percentage of net revenue from domestic sale for potential aggregate payments 20.00%